James Edgemond - Sep 9, 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
CFO AND TREASURER
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Sep 9, 2024
Transactions value $
-$1,703,508
Form type
4
Date filed
9/10/2024, 04:30 PM
Previous filing
Sep 4, 2024
Next filing
Sep 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $393K +3.27K +101.74% $120.26 6.48K Sep 9, 2024 Direct F1, F2
transaction UTHR Common Stock Sale -$1.13M -3.27K -50.43% $345.41 3.21K Sep 9, 2024 Direct F1
transaction UTHR Common Stock Options Exercise $400K +3.4K +105.92% $117.76 6.61K Sep 9, 2024 Direct F1
transaction UTHR Common Stock Sale -$1.17M -3.4K -51.44% $345.41 3.21K Sep 9, 2024 Direct F1
transaction UTHR Common Stock Options Exercise $98.1K +816 +25.42% $120.26 4.03K Sep 9, 2024 Direct F1, F3
transaction UTHR Common Stock Sale -$193K -558 -13.86% $345.41 3.47K Sep 9, 2024 Direct F1, F3
transaction UTHR Common Stock Options Exercise $100K +850 +24.51% $117.76 4.32K Sep 9, 2024 Direct F1, F4
transaction UTHR Common Stock Sale -$200K -578 -13.39% $345.41 3.74K Sep 9, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -3.27K -8.89% $0.00 33.5K Sep 9, 2024 Common Stock 3.27K $120.26 Direct F1
transaction UTHR Stock Options Options Exercise $0 -3.4K -2.27% $0.00 146K Sep 9, 2024 Common Stock 3.4K $117.76 Direct F1
transaction UTHR Stock Options Options Exercise $0 -816 -2.44% $0.00 32.7K Sep 9, 2024 Common Stock 816 $120.26 Direct F1, F3
transaction UTHR Stock Options Options Exercise $0 -850 -0.58% $0.00 146K Sep 9, 2024 Common Stock 850 $117.76 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 17, 2024.
F2 Includes 48 shares of common stock acquired on September 4, 2024 under the United Therapeutics Corporation Employee Stock Purchase Plan.
F3 This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 816 stock options, sold 558 of the resulting shares of common stock, and held the remaining 258 shares of common stock.
F4 This option exercise was a "sell-to-cover" transaction whereby the reporting person exercised 850 stock options, sold 578 of the resulting shares of common stock, and held the remaining 272 shares of common stock.